Outcomes of stereotactic radiosurgery for spine multiple myeloma-a systematic review.

Neurosurg RevSep 14, 2026 (epub)
Clinical ResearchOncology (Medical)Open access

Muhammad Izhar, Yusuke S Hori, Ahed H Kattaa et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review assessed the outcomes of stereotactic radiosurgery (SRS) for spinal multiple myeloma, analyzing three retrospective studies involving 133 patients. The review found local control rates between 89.4% and 100%, with pain improvement in 41-88% of patients. Median follow-up ranged from 11.2 to 27.8 months.

Key findings

  • Local control rates for SRS ranged from 89.4% to 100%.
  • Pain improvement was reported in 41-88% of treated patients/sites.
  • Neurological improvement occurred in 56-71.4% of patients with preexisting deficits.
  • De novo vertebral fractures ranged from 3.6% to 7%.

Why it matters

Understanding the efficacy and safety of SRS for spinal multiple myeloma is crucial for clinicians considering treatment options that minimize damage to surrounding tissues while effectively managing disease symptoms.

What to keep in mind

The evidence is limited to small retrospective studies with heterogeneous reporting.

Source

Published in Neurosurg Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.